JBC Ideal method for primary cell transfection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M607571200 on September 13, 2006

J. Biol. Chem., Vol. 281, Issue 46, 35081-35087, November 17, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
281/46/35081    most recent
M607571200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindvall, C.
Right arrow Articles by Williams, B. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindvall, C.
Right arrow Articles by Williams, B. O.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Wnt Signaling Receptor Lrp5 Is Required for Mammary Ductal Stem Cell Activity and Wnt1-induced Tumorigenesis*Formula

Charlotta Lindvall{ddagger}, Nicole C. Evans{ddagger}, Cassandra R. Zylstra{ddagger}, Yi Li§, Caroline M. Alexander1, and Bart O. Williams{ddagger}2

From the {ddagger}Laboratory of Cell Signaling and Carcinogenesis, Van Andel Research Institute, Grand Rapids, Michigan 49503, the §Breast Center, Baylor College of Medicine, Houston, Texas 77030, and the McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin 53706

Canonical Wnt signaling has emerged as a critical regulatory pathway for stem cells. The association between ectopic activation of Wnt signaling and many different types of human cancer suggests that Wnt ligands can initiate tumor formation through altered regulation of stem cell populations. Here we have shown that mice deficient for the Wnt co-receptor Lrp5 are resistant to Wnt1-induced mammary tumors, which have been shown to be derived from the mammary stem/progenitor cell population. These mice exhibit a profound delay in tumorigenesis that is associated with reduced Wnt1-induced accumulation of mammary progenitor cells. In addition to the tumor resistance phenotype, loss of Lrp5 delays normal mammary development. The ductal trees of 5-week-old Lrp5-/- females have fewer terminal end buds, which are structures critical for juvenile ductal extension presumed to be rich in stem/progenitor cells. Consequently, the mature ductal tree is hypomorphic and does not completely fill the fat pad. Furthermore, Lrp5-/- ductal cells from mature females exhibit little to no stem cell activity in limiting dilution transplants. Finally, we have shown that Lrp5-/- embryos exhibit substantially impaired canonical Wnt signaling in the primitive stem cell compartment of the mammary placodes. These findings suggest that Lrp5-mediated canonical signaling is required for mammary ductal stem cell activity and for tumor development in response to oncogenic Wnt effectors.


Received for publication, August 9, 2006 , and in revised form, September 13, 2006.

* This work was supported by the Van Andel Research Institute, National Institutes of Health RO1 CA113869-01 (to Y. L.), Susan G. Komen Breast Cancer Foundation Grant BCTR 0202106 (to C. M. A.), and a fellowship from the Wenner-Gren Foundation (to C. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. S1.

1 To whom correspondence may be addressed: McArdle Laboratory for Cancer Research, University of Wisconsin, 1400 University Ave. Madison, WI 53706. Tel.: 608-265-5182; Fax: 608-262-2824; E-mail: alexander{at}oncology.wisc.edu. 2 To whom correspondence may be addressed: Laboratory of Cell Signaling and Carcinogenesis, Van Andel Research Inst., 333 Bostwick Ave. NE, Grand Rapids, MI 49504. Tel.: 616-234-5308; Fax: 616-234-5309; E-mail: Bart.Williams{at}vai.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DevelopmentHome page
C. J. Watson and W. T. Khaled
Mammary development in the embryo and adult: a journey of morphogenesis and commitment
Development, March 15, 2008; 135(6): 995 - 1003.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
R. Villadsen, A. J. Fridriksdottir, L. Ronnov-Jessen, T. Gudjonsson, F. Rank, M. A. LaBarge, M. J. Bissell, and O. W. Petersen
Evidence for a stem cell hierarchy in the adult human breast
J. Cell Biol., April 9, 2007; 177(1): 87 - 101.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.